Administration of ribavirin within 96 hours of symptom onset in patients with Crimean-Congo hemorrhagic fever was associated with a reduced risk for mortality, while age 50 years or more and diabetes ...
Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery programmable therapeutics, and point-of-care diagnostics, today announced an expansion of its Global Disease ...